AMPK indirectly downregulates expression of the 1C metabolism enzymes, MTHFD1, MTHFD1L and MTHFD2 in breast cancer, raising the possibility that AMPK activators may sensitize cancers to anti-folate therapy85. Here, MTHFD1L is linked to breast carcinoma.